Gufic Biosciences Limited · NSE:GUFICBIO
Gufic Biosciences — Investor Presentation (March 2019)
38 slides from Gufic Biosciences's investor presentation, March 2019
Slide 1: Corporate & Investor Presentation
CORPORATE & INVESTOR Corporate and Investor PRESENTATION Presentation
Slide 2: Elevator Pitch
ELEVATOR PITCH Gufic Biosciences, with its It has heavily invested in With all this Gufic Biosciences Research & Development advanced automation is all set to ensure sustainable (R&D) prowess, is accredited technologies and IT value creation for all its with several pioneering infrastructure stakeho
Slide 3: Corporate Overview
CORPORATE OVERVIEW
Slide 4: Gufic Biosciences: About the Company
GUFIC BIOSCIENCES: ABOUT THE COMPANY Gufic Biosciences Ltd is a fast-growing pharmaceutical player recognized for its innovative, high-quality pharmaceutical and herbal products and a wide range of APIs (Active Pharmaceutical Ingredients) Established in 1984, it is a part of the Gufic Group that c
Slide 5: About the Gufic Group
ABOUT THE GUFIC GROUP Gufic Group operates with the vision of achieving leadership in the specialized medical segment, while making products affordable using innovation and technology Reputation: Corporate Structure: PIONEERING SPECIALITIES BLOCK BUSTER GUFIC Group INITIATIVES Lyophilized BRANDS
Slide 6: About Gufic Lifesciences
ABOUT GUFIC LIFESCIENCES Gufic Lifesciences Pvt. Ltd. (GLPL) is a WHO GMP, EU GMP and Ukraine GMP approved company with a total capacity of 1.2 million lyophilized vials a month Its lyophilized product portfolio includes Antibiotic, Antifungal, Cardiac, Infertility, Antiviral and proton-pump inh
Slide 7: Mission and Vision
DRIVEN BY THE VISION TO MAKE SPECIALIZED HEALTHCARE AFFORDABLE MISSION Leadership in Healthcare Through Innovation and Quality VISION To achieve leadership in the specialized medicinal segments and make products available at a cost-effective rate using innovation and technology to enhance the welfar
Slide 8: Journey Over the Years (Pre 2000)
JOURNEY OVER THE YEARS PRE 2000 1970s 1975 1984 1997 1st Indian Company to Introduced in India 1st company to First time to manufacture and import a Lyophilizer (from Lyophilized B-Lactum commercially produce market silver sulphadiazine eye Stokes, USA) to produce Injections (Amoxicillin) Bo
Slide 9: Journey Over the Years (Post 2000)
JOURNEY OVER THE YEARS POST 2000 2000-2006 2011-2016 2018 Focused on consumer Received patents for Anidulafungin Amalgamated with Gufic Stridden Bio-Pharma Pvt Ltd, products like Roll-on, and Tigecycline Lyophilized products which shall boost export opportunities in countries Stretch Nil, Oner
Slide 10: Business Segments: Criticare & Criticare Life
BUSINESS SEGMENTS Key product offerings: CRITICARE & CRITICARE LIFE Initiated in 2015 ~40% contribution to Company’s revenues 900+ hospitals penetration Fastest growing Criticare division in India 3rd largest supplier of injectable antibiotics to hospitals Expertise in manufacturing affo
Slide 11: Business Segments: Gufic Ferticare
BUSINESS SEGMENTS Key product offerings: GUFIC FERTICARE Initiated in 2016 Provides comprehensive fertility care through innovative, high-quality products Manufacturing hormonal injectable since 8 years and has a dedicated hormone manufacturing block Caters to manufacturing of hormonal produ
Slide 12: Business Segments: Gufic Spark
BUSINESS SEGMENTS Key product offerings: GUFIC SPARK High thrust division 200+ dedicated field representatives Caters ~25,000 General/Clinical practitioners, Pediatrician and Gynecologists Launched 1st time in India: o Cough syrup with oral dosing syringe o Sertaconazole in ointment o Lactic
Slide 13: Business Segments: Gufic Healthcare
BUSINESS SEGMENTS Key product offerings: GUFIC HEALTHCARE Leading manufacturer of specialized herbal medicines in India Manufacturing unit in Belgaum, Karnataka, India SALLAKI (Boswellia Serrata) – the flagship brand of the division has been the frontrunner for 35+ years in India and many Euro
Slide 14: Business Segments: Gufic Bulk Drugs
BUSINESS SEGMENTS Key product offerings: Bulk Drugs GUFIC BULK DRUGS GUFIC offers a varied therapeutic basket in its Bulk drugs/API division. The categories of API’s manufactured are antifungals, antibacterial, anesthetics and intermediates for antifungals
Slide 15: Manufacturing Facilities and Capacities: Navsari Plant
MANUFACTURING FACILITIES AND CAPACITIES NAVSARI PLANT CAPACITY: CERTIFICATIONS: Lyophilizer – 14.4 million(mn) WHO GMP vials per annum(p.a.) Philippines BFAD Ampoule – 12 mn p.a. Nigeria NAFDAC Ointment – 6 mn tubes p.a. Cambodia MOH Lotion – 6 mn bottles p.a. Kenya PPB Syrup – 6
Slide 16: Manufacturing Facilities and Capacities: Baroda and Belgaum Plants
MANUFACTURING FACILITIES AND CAPACITIES BARODA PLANT CAPACITY: Sanitary napkins – 0.7 mn per day KEY FEATURES: Equipped with automatic machine from Italy and China BELGAUM PLANT CAPACITY: 60 mn capsules p.a. 3.6 mn powder p.a. KEY FEATURES: Product manufactured is registered and exported t
Slide 17: Presence in Strategic Locations Across the Globe
PRESENCE IN STRATEGIC LOCATIONS ACROSS THE GLOBE Our operations is spread across pan- India* and 23+ other countries worldwide Note Pan-India excludes: Gufic Spark – Delhi, Orissa, Jammu & Kashmir (J&K), Himachal Pradesh (HP) and North-East (NE) * Gufic Healthcare – J&K and NE *Gufic Ferticare – J&K
Slide 18: Our Strengths
OUR STRENGTHS WELL-ENTRENCHED GROWING PRESENCE PROFESSIONAL MANUFACTURING PRESENCE IN INDIA GLOBALLY MANAGEMENT EXCELLENCE Pan-India distribution Product exports 30+ years average Full scale commercial network with 1400 across 23+ countries experience of senior manufacturing with investments
Slide 19: Financials
a v FINANCIALS
Slide 20: Financial Highlights
FINANCIAL HIGHLIGHTS GUFIC BIOSCIENCES LTD – COMPARATIVE ANALYSIS Revenue from operations (Rs. in millions) Profit After Tax (Rs. in millions) 4000 3041.19 200 160.21 3000 2604.17 150 2021.98 90.21 2000 1230.11 1515.51 100 73.24 42.64 41.57 1000 50 0 0 FY14 FY15 FY16 FY17 FY18 FY14 FY15 FY16 FY17 FY
Slide 21: Key Business Enablers
KEY BUSINESS ENABLERS
Slide 22: Key Enablers
KEY ENABLERS KEY ENABLERS R&D Marketing Supply Chain Technology API synthesis, first generic Core competency of super Integrated distribution Upgraded hardware launch, research collaboration specialty business network across the entire infrastructure to virtualized and licensing of New drug
Slide 23: Strategic Growth Plan
STRATEGIC . all » GROWTH | i
Slide 24: Way Forward
WAY FORWARD STRENGTHEN OFFERING EXPLORE API DEVELOPMENT Leverage collaboration with US, EU With government strongly focused and China based companies to on bringing down healthcare costs, strengthen pipeline and enter the Gufic is focused on achieving cost field of cosmetics, immune- efficiency
Slide 25: Promoter, Board of Director and Management Profiles
PROMOTER, BOARD OF DIRECTOR AND MANAGEMENT PROFILES
Slide 26: Founder
FOUNDER Late Shri Pannalal S. Choksi, Founder He was a B-Pharm from L. M. College of Pharmacy, Ahmedabad. He started the Company in 1970 and is accredited as being the first to launch blockbuster drugs in Antibiotics and Antifungals like Mox (Amoxycillin), Doxycycline inj, Zole (Micanazole Nitrate)
Slide 27: Senior Management
SENIOR MANAGEMENT Mr. Jayesh P. Choksi, Chairman and Managing Director He is a Bachelor in Pharmacy with 40+ years of experience in the pharma sector. Under his stewardship, the Company has seen great success and diversified to Critical Care, Infertility, API manufacturing, Healthcare and Pharma ver
Slide 28: Senior Management
SENIOR MANAGEMENT Mr. Pranav J. Choksi, CEO & Whole Time Director He is a Bachelor in Pharmacy from the Institute of Chemical Technology, University of Mumbai and have done Masters in Biotechnology from The John Hopkins University, USA and. He has specialization in Autologous Cancer Vaccines in the
Slide 29: Key Managerial Personnel
KEY MANAGERIAL PERSONNEL Mr. D.B.Roonghta Chief Financial Officer He is a qualified Chartered Accountant with nearly 30 years of rich experience in corporate finance. He is experienced in leading the design of optimum capital structure and financial strategy . He is an enterprising leader who has ef
Slide 30: Key Management Personnel
KEY MANAGEMENT PERSONNEL Mr. Mafatlal T. Dave Technical Head He is a B. Sc. (Chemistry, Physics) from Mumbai University and an A.I.C. (Associate of Institution of Chemist) from Chemist Institute, Calcutta. Initiating his career as an Assistant – Chemist at Therapeutic Chemical Research corporation,
Slide 31: Board of Directors
BOARD OF DIRECTORS Dr. Balram Singh, Non-Executive Director He is a B. Sc. (Chemistry, Biology), M. Sc. (Life Sciences, Major-Biochemistry) and M. Phil (Life sciences, Major-Biophysical chemistry) from India. He is doctorate in Chemistry with major in Biophysical Chemistry from Texas Tech University
Slide 32: Board of Directors
BOARD OF DIRECTORS Mrs. Hemal Milan Desai Whole Time Executive Director She is Cost Accountant from ICMA and has over 29 years of experience in the pharmaceutical industry, 24 years of which have been with Gufic. She heads Direct and Indirect Taxation and is also responsible for overseeing Cost & NP
Slide 33: Board of Directors
BOARD OF DIRECTORS Mr. Shreyas Kantilal Patel Independent Director He has rich experience of over 35 years in the engineering industry. He is an entrepreneur with a manufacturing facility for fabrication of press parts in Nasik. Mr. Jagdish Dwarkadas Shah Independent Director He is a Chartered Accou
Slide 34: Human Resources & Corporate Citizenship
HUMAN RESOURCES & CORPORATE CITIZENSHIP
Slide 35: Nurturing Talent
NURTURING TALENT GUFIC HAS A TOTAL At Gufic, we believe in the age-old Chinese proverb – OF 1,000+ “If you want one year of prosperity, grow grain. If you want ten years of EMPLOYEES ACROSS prosperity, grow trees. If you want one hundred years of prosperity, grow people” INDIA AND 20+ IN OVERSEAS MA
Slide 36: Corporate Citizenship
CORPORATE CITIZENSHIP COMMUNITY EDUCATION, SOCIAL CARE Gufic’s strong focus on promoting HEALTHCARE, KNOWLEDGE AND AND CONCERN and supporting the cause of child SANITATION AND RESEARCH Generate employment education has been recognized by HYGIENE Assist underprivileged opportunities Smile Foundat
Slide 37: Safe Harbour Statement
SAFE HARBOUR STATEMENT The information contained in this presentation is only current as of its date. All actions and statements made herein or otherwise shall be subject to the applicable laws and regulations as amended from time to time. There is no representation that all information relating to
Slide 38: Thank you
Thank you Gufic Biosciences Limited Regd. Office: 37, 1st Floor, Kamala Bhavan II, Swami Nityanand Road, Andheri (East), Mumbai - 400 069. (INDIA) Corp. Office: 1st to 4th Floor, S.M. House, 11 Sahakar Road, Vile Parle (East), Mumbai – 400 057. (INDIA) Tel.: +91 22 67261000 Website: www.gufic.com Em
Gufic Biosciences — Investor Presentation (March 2019) on 6ix